ライフサイエンスコーパス: scatter factor

1 he MET ligand HGF (hepatocyte growth factor, scatter factor).

2 t growth factor, or hepatocyte growth factor/scatter factor.

3 whose ligand is hepatocyte growth factor and scatter factor.

4 Met activation with hepatocyte growth factor/scatter factor.

5 ctivation of Met by hepatocyte growth factor/scatter factor.

6 nd -2 as well as to hepatocyte growth factor/scatter factor.

7 Met and its ligand hepatocyte growth factor/scatter factor.

8 n and the temperature dependence of the Hall scattering factor.

9 r materials by the free refinement of atomic scattering factors.

10 finement of X-ray energy-dependent anomalous scattering factors.

11 active fragment of hepatocyte growth factor/scatter factor, 1K1, which acts as a potent angiogenic a

12 ilarities to hepatocyte growth factor (HGF; "scatter factor"), a promoter of angiogenesis, that induc

13 ast cells, hydrolyze HGF, thereby abolishing scatter factor activity while generating an NK4-like ant

14 synovial tissue fibroblast antigenic HGF and scatter factor activity.

15 ile generating an NK4-like antagonist of HGF scatter factor activity.

16 f the mutant HS for hepatocyte growth factor/scatter factor and fibronectin were unchanged but were r

17 nvolving the use of hepatocyte growth factor/scatter factor and selected extracellular matrices, we o

18 factor-BB, transforming growth factor-beta, scatter factor, and granulocyte macrophage-colony stimul

19 larly Oncostatin M, hepatocyte growth factor/scatter factor, and interferon-gamma, were found to indu

20 n on the sample characteristics, absorption, scattering factor, and coherent phonon energies and popu

21 d its ligand, hepatocyte growth factor (HGF)/scatter factor are involved in the etiology and progress

22 Met and its ligand hepatocyte growth factor/scatter factor are promising targets for the novel thera

23 e HGF was biologically active, an epithelial scatter factor assay was performed.

24 ls to nicotinamide, hepatocyte growth factor/scatter factor, betacellulin, activin A, or exendin-4 fa

25 Hepatocyte growth factor/scatter factor c-met signaling pathway is of central imp

26 ion across the Al K edge, where the aluminum scattering factor changes dramatically.

27 MAD-derived atomic scattering factor data emphasize in-edge features that a

28 comparing the entire envelope of the atomic scattering factor data.

29 ne termed hepatocyte growth factor (HGF), or scatter factor (due to its ability to disperse cohesive

30 kinase receptor for hepatocyte growth factor/scatter factor encoded by the c-met protooncogene is als

31 n levels are evident by systematic shifts of scattering factor envelopes to increasingly higher energ

32 a member of the Met/hepatocyte growth factor/scatter factor family of receptor protein tyrosine kinas

33 tracellular domain of c-Met, a member of the scatter factor family of receptors.

34 ) is a receptor tyrosine kinase (RTK) in the scatter factor family, which includes the c-Met receptor

35 ly a small amount of aluminum, and the X-ray scattering factors for silicon and aluminum are very sim

36 c activity of hepatocyte growth factor (HGF)/scatter factor has been closely associated with its abil

37 se receptor for the hepatocyte growth factor/scatter factor, has been implicated in the progression a

38 al distinction from the archetypal motogenic scatter factors hepatocyte growth factor and macrophage

39 The cytokine scatter factor/hepatocyte growth factor (HGF/SF) protect

40 c-Met activation by scatter factor/hepatocyte growth factor (SF/HGF) altered

41 The role of the growth factor scatter factor/hepatocyte growth factor (SF/HGF) and its

42 The multifunctional growth factor scatter factor/hepatocyte growth factor (SF/HGF) and its

43 Scatter factor/hepatocyte growth factor (SF/HGF) can sti

44 Scatter factor/hepatocyte growth factor (SF/HGF) express

45 Scatter factor/hepatocyte growth factor (SF/HGF) is a mu

46 Scatter factor/hepatocyte growth factor (SF/HGF) is a pl

47 MDCK cells were then stimulated with scatter factor/hepatocyte growth factor (SF/HGF) to init

48 ntly that the multifunctional growth factor, scatter factor/hepatocyte growth factor (SF/HGF), and it

49 regulated by the epidermal growth factor and scatter factor/hepatocyte growth factor receptors.

50 abolishes epidermal growth factor (EGF)- or scatter factor/hepatocyte growth factor-dependent colony

51 ctor-induced motility also eliminate EGF- or scatter factor/hepatocyte growth factor-dependent induct

52 In this study we have used a scatter factor/hepatocyte growth factor-induced model sy

53 Transcripts for hepatocyte growth factor/scatter factor (HGF) and its receptor are coexpressed tr

54 Hepatocyte growth factor/scatter factor (HGF) and the angiogenesis factors platel

55 hymal expression of hepatocyte growth factor/scatter factor (Hgf), which encodes a secreted ligand th

56 egatively regulates hepatocyte growth factor/scatter factor (HGF)-induced branching morphogenesis in

57 t, the receptor for hepatocyte growth factor/scatter factor (HGF).

58 Hepatocyte growth factor-scatter factor (HGF-SF) is a potent hepatic mitogen yet

59 e day of treatment, hepatocyte growth factor/scatter factor (HGF/ SF)-stimulated MDCK cysts initiated

60 Both exposure to hepatocyte growth factor/scatter factor (HGF/SF) and dispersion of the cells by r

61 th high affinity to hepatocyte growth factor/scatter factor (HGF/SF) and function as necessary co-fac

62 leiotropic cytokine hepatocyte growth factor/scatter factor (HGF/SF) and its receptor c-met were comp

63 and motility factor hepatocyte growth factor/scatter factor (HGF/SF) and its receptor MET, the tyrosi

64 ntary expression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor, MET, in the fo

65 The expression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor, the c-met prot

66 and motility factor Hepatocyte Growth Factor/Scatter Factor (HGF/SF) and its receptor, the product of

67 at the intensity of hepatocyte growth factor/scatter factor (HGF/SF) and Met staining in human primar

68 e ligand for Met is hepatocyte growth factor/scatter factor (HGF/SF) and while normal HGF/SF-Met sign

69 g protein (MSP) and hepatocyte growth factor/scatter factor (HGF/SF) are plasminogen-related growth a

70 chromatography that hepatocyte growth factor/scatter factor (HGF/SF) binds strongly to dermatan sulfa

71 Hepatocyte growth factor/scatter factor (HGF/SF) has a cofactor requirement for h

72 The cytokine hepatocyte growth factor/scatter factor (HGF/SF) has been found to protect a vari

73 Since hepatocyte growth factor/scatter factor (HGF/SF) has been reported to promote ker

74 EGF - is induced by hepatocyte growth factor/scatter factor (HGF/SF) in human lung cancer cell lines.

75 priately expressing hepatocyte growth factor/scatter factor (HGF/SF) in the skin as an experimental m

76 activating it in a hepatocyte growth factor/scatter factor (HGF/SF) independent manner.

77 mice transgenic for hepatocyte growth factor/scatter factor (HGF/SF) induces RMS with extremely high

78 Hepatocyte growth factor/scatter factor (HGF/SF) is a heparin-binding polypeptide

79 Hepatocyte growth factor/scatter factor (HGF/SF) is a mesenchymally derived, mult

80 Hepatocyte growth factor/scatter factor (HGF/SF) is a multifunctional cytokine ca

81 Hepatocyte growth factor/scatter factor (HGF/SF) is a pleiotropic effector of cel

82 Hepatocyte growth factor/scatter factor (HGF/SF) is a pluripotent growth factor c

83 Hepatocyte growth factor/scatter factor (HGF/SF) is a potent mitogen, motogen, an

84 Hepatocyte growth factor/scatter factor (HGF/SF) is considered to be a mesenchyma

85 Hepatocyte growth factor/scatter factor (HGF/SF) is expressed in the developing l

86 Hepatocyte Growth Factor/Scatter Factor (HGF/SF) mediates a wide variety of cellu

87 leiotropic molecule hepatocyte growth factor/scatter factor (HGF/SF) mediates interneuron migration.

88 The hepatocyte growth factor/scatter factor (HGF/SF) plays a critical role in the reg

89 activator (uPA) by hepatocyte growth factor/scatter factor (HGF/SF) plays an important role in tumor

90 Hepatocyte growth factor/scatter factor (HGF/SF) plays important roles in mammali

91 Hepatocyte growth factor/scatter factor (HGF/SF) possesses mitogenic, motogenic,

92 ant to activate the hepatocyte growth factor/scatter factor (HGF/SF) promoter using chloramphenicol a

93 Hepatocyte growth factor/scatter factor (HGF/SF) promotes the proliferation, diff

94 The cytokine hepatocyte growth factor/scatter factor (HGF/SF) protects epithelial and cancer c

95 The hepatocyte growth factor/scatter factor (HGF/SF) receptor c-Met and variants of t

96 Aberrations in Met-hepatocyte growth factor/scatter factor (HGF/SF) signaling have been implicated i

97 Hepatocyte growth factor/scatter factor (HGF/SF) stimulates cell proliferation, m

98 Hepatocyte growth factor/scatter factor (HGF/SF) stimulates hepatocyte DNA synthe

99 Hepatocyte growth factor/scatter factor (HGF/SF) stimulates numerous cellular act

100 opically expressing hepatocyte growth factor/scatter factor (HGF/SF) to show that the Met signaling p

101 the interaction of hepatocyte growth factor/scatter factor (HGF/SF) with the receptor tyrosine kinas

102 ogene (receptor for hepatocyte growth factor/scatter factor (HGF/SF)) in interconverted uveal melanom

103 chemoattractant as hepatocyte growth factor/scatter factor (HGF/SF), a diffusible ligand for the c-M

104 Hepatocyte growth factor/scatter factor (HGF/SF), acting through the Met receptor

105 ase and its ligand, hepatocyte growth factor/scatter factor (HGF/SF), have been implicated in human t

106 t, the receptor for hepatocyte growth factor/scatter factor (HGF/SF), is overexpressed in epithelial

107 kinase receptor for hepatocyte growth factor/scatter factor (HGF/SF), is significantly up-regulated i

108 t, the receptor for hepatocyte growth factor/scatter factor (HGF/SF), might represent a characteristi

109 Met and its ligand, hepatocyte growth factor/scatter factor (HGF/SF), modulate signaling cascades imp

110 mice overexpressing hepatocyte growth factor/scatter factor (HGF/SF), or its growth antagonist NK2, a

111 tide growth factor, hepatocyte growth factor/scatter factor (HGF/SF), shares the multidomain structur

112 Hepatocyte growth factor/scatter factor (HGF/SF), the ligand for the receptor tyr

113 mice transgenic for hepatocyte growth factor/scatter factor (HGF/SF), to identify a set of genes whos

114 trict regulation of hepatocyte growth factor/scatter factor (HGF/SF)-Met signaling is essential for i

115 y, we reported that hepatocyte growth factor/scatter factor (HGF/SF)-transgenic mice develop melanoma

116 ypes in response to hepatocyte growth factor/scatter factor (HGF/SF).

117 tion by its ligand, hepatocyte growth factor/scatter factor (HGF/SF).

118 se receptor for the hepatocyte growth factor/scatter factor (HGF/SF).

119 sive in response to hepatocyte growth factor/scatter factor (HGF/SF).

120 ne and receptor for hepatocyte growth factor/scatter factor (HGF/SF).

121 ceptor activated by hepatocyte growth factor/scatter factor (HGF/SF).

122 cement of autocrine hepatocyte growth factor/scatter factor (HGF/SF)/c-Met signaling.

123 Hepatocyte growth factor (scatter factor) (HGF/SF) is a pleiotrophic mediator of e

124 r the influence of hepatocyte growth factor (scatter factor) (HGF/SF), epidermal growth factor (EGF),

125 ailed to respond to hepatocyte growth factor/scatter factor, implying that hepatic PBP deficiency aff

126 hat copurified with hepatocyte growth factor/scatter factor in conditioned medium from a human embryo

127 by its ligand hepatocyte growth factor (HGF)/scatter factor in some CCS cell lines.

128 Hepatocyte growth factor/scatter factor, in addition to binding to its specific s

129 correlated with the hepatocyte growth factor/scatter factor-induced downregulation or nicotinamideind

130 Full-length hepatocyte growth factor/scatter factor interacts with both heparan and dermatan

131 Hepatocyte growth factor (scatter factor) is an angiogenic growth factor that bind

132 e ligand for c-met (hepatocyte growth factor/scatter factor) is expressed at high levels.

133 lso able to promote hepatocyte growth factor/scatter factor-mediated activation of Met and consequent

134 ll as inhibition of hepatocyte growth factor/scatter factor-mediated scattering and invasion in vitro

135 he receptor for the hepatocyte growth factor/scatter factor Met leads to receptor monoubiquitination

136 Hepatocyte growth factor/scatter factor-Met signaling has been implicated in tumo

137 We refer to this new concept as ionic scattering factors modelling.

138 The comparatively low scattering factor of nuclei of the organic capping ligan

139 cells treated with hepatocyte growth factor/scatter factor or cell lines stably expressing activated

140 h factor-alpha, and hepatocyte growth factor/scatter factor or conditioned media from tumor-associate

141 gand for c-Met, pro-hepatocyte growth factor/scatter factor (proHGF/SF), through c-Met and Gab1 signa

142 rmational change in hepatocyte growth factor/scatter factor, rather than to induce a necessary growth

143 have identified the hepatocyte growth factor/scatter factor receptor Met, the adapter protein Gab1, a

144 c-met protooncogene (a hepatic growth factor/scatter factor receptor).

145 plexins, which belong to the c-Met family of scatter factor receptors but lack an intrinsic tyrosine

146 teraction module also present in plexins and scatter-factor receptors.

147 atocyte growth factor (HGF), also known as a scatter factor, regulates a variety of biological activi

148 d T47D cells in culture by treating with HGF/scatter factor resulted in a loss of CLDN-7 expression w

149 ors (VEGF, bFGF, or hepatocyte growth factor/scatter factor), resulted in a dramatic reduction in the

150 Scatter factor (SF) (hepatocyte growth factor) is a cyto

151 Scatter factor (SF) (hepatocyte growth factor) is a plei

152 Scatter factor (SF) (hepatocyte growth factor) is a plei

153 The cytokine scatter factor (SF) (hepatocyte growth factor) transduce

154 Scatter factor (SF) [aka. hepatocyte growth factor (HGF)

155 -Met receptor tyrosine kinase and its ligand Scatter Factor (SF) are necessary for the migration of h

156 Scatter factor (SF) is an angiogenic growth factor that

157 Scatter factor (SF) is an invasogenic and angiogenic cyt

158 hepatocyte growth factor (HGF), also called scatter factor (SF), and its receptor c-Met are associat

159 receptor (EGFR) or hepatocyte growth factor/scatter factor (SF)-c-Met interactions.

160 Hepatocyte growth factor (HGF), also called scatter factor, stimulates growth and motility in nonocu

161 riptase can convert hepatocyte growth factor/scattering factor to its active form, which can induce s

162 findings using the hepatocyte growth factor/scatter factor transgenic mouse model, which develops le

163 , together with our hepatocyte growth factor/scatter factor-transgenic mouse model of UV-induced mela

164 hown that all three hepatocyte growth factor/scatter factor variants share identical heparan/dermatan

165 effects were explored that can impact atomic scattering factors within clusters, including 1) metal a